Φορτώνει......
Immune-related alopecia (areata and universalis-type) in cancer patients receiving immune checkpoint inhibitors
CTLA-4, PD-1, and PD-L1 monoclonal antibodies, commonly known as immune checkpoint inhibitors, are used for the treatment of various malignancies. The mechanism of action involves the inhibition of negative regulators of immune activation, which results in many patients developing immune-related adv...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Br J Dermatol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5459625/ https://ncbi.nlm.nih.gov/pubmed/27943234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.15237 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|